drugset / Trial / NCT00156403
A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis
Phase 1/2
Completed
8 enrolled
University of Pittsburgh
National Center for Research Resources (NCRR) · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This pilot study is a feasibility, safety, and preliminary benefits study to look at whether giving the calcium channel blocker amlodipine to people with hereditary pancreatitis as a prophylactic measure can reduce the inflammatory process in the pancreas.
Timeline
- Start
- 2005-08
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | — | Oral |